Opioid Market Envisaged to Reach USD 28.45 billion by 2034, With a CAGR of 1.8% from 2025 - 2034

𝐎𝐩𝐢𝐨𝐢𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐒𝐢𝐳𝐞 𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐎𝐮𝐭𝐥𝐨𝐨𝐤, 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐚𝐧𝐝 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬. 𝐓𝐡𝐞 𝐨𝐩𝐢𝐨𝐢𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟐𝟑.𝟕𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐭𝐨 𝐔𝐒𝐃 𝟐𝟖.𝟒𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏.𝟖% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟒

𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐜𝐨𝐩𝐞:
This comprehensive study provides an accurate overview of the worldwide opioid market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by class, product, release type, application, and region in the study, which offers a comprehensive picture of the state of the market.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/opioid-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
An opioid refers to a category of drugs that encompasses both prescribed pain medications, such as morphine and oxycodone, as well as illicit drugs, like. Opioids function by attaching to receptors in the brain and nervous system, alleviating pain and generating sensations of euphoria. Although useful for alleviating pain, opioids pose a significant risk of addiction, overdose, and dependence, contributing to the persistent opioid crisis in several nations.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬:
● The necessity to address the intricate pain needs of trauma patients is anticipated to result in a rise in opioid prescriptions. The increasing occurrence of traumatic injuries significantly fuels the growth of the market.

● Government spending on healthcare to enhance infrastructure and diminish inequalities between urban and rural healthcare environments is anticipated to propel opioid market growth throughout the forecast period. Rising healthcare expenditures globally, coupled with an emphasis on enhancing healthcare access in neglected regions, are expected to lead to a rise in opioid prescriptions.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:
In a highly competitive environment, leading competitors continually strive to innovate and distinguish their products to gain a competitive advantage in the market. Here are the top companies in the market:

• Aurobindo Pharma Limited
• Assertio Therapeutics, Inc.
• AbbVie Inc.
• Actavis Plc.
• Amneal Pharmaceuticals LLC
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Limited
• Fresenius Kabi
• Mallinckrodt Pharmaceuticals
• Endo International plc
• Johnson & Johnson Corporation

𝐎𝐩𝐢𝐨𝐢𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• By release type, the extended-release/long-acting opioid segment is anticipated to experience substantial growth at a significant CAGR in the global market during the forecast period. This growth is attributed to an increase in the prevalence of extended pain and traumatic injuries requiring long-acting opioids.

• The pain management segment, by application, accounted for the largest revenue share of the market in 2024 due to the rising number of chronic and acute injuries.

• In 2024, North America dominated the global opioid market share due to the increasing number hospitals, leading to the increase in prescription rate.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

By Class Outlook (Revenue - USD Billion, 2020-2034)
 Natural
 Semi-Synthetic
 Fully Synthetic

By Product Outlook (Revenue - USD Billion, 2020-2034)
 Codeine
 Fentanyl
 Oxycodone
 Methadone
 Morphine
 Hydrocodone
 Propoxyphene
 Others

By Release Type Outlook (Revenue - USD Billion, 2020-2034)
 Immediate-Release/Short-Acting Opioid
 Extended-Release/Long-Acting Opioid

By Application (Revenue - USD Billion, 2020-2034)
 Pain Management
 Neuropathic
 Migraine
 Orthopedic and Musculoskeletal
 Arthritis
 Fibromyalgia
 Others
 Cancer Pain
 Brain
 Breast
 Colorectal
 Blood
 Skin
 Prostate
 Others
 Cough Treatment
 Analgesia
 Diarrhea Treatment
 De-addiction
 Others

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
According to regional analysis, North America held the largest revenue share in the market in 2024 due to its enhanced healthcare infrastructure, which promotes increased prescription rates for pain relief. Also, Asia Pacific is anticipated to experience the highest CAGR during the projection period, driven by increased population density and rising healthcare needs.

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Plasma Protease C1-inhibitor Market
https://www.polarismarketresearch.com/industry-analysis/plasma-protease-c1-inhibitor-market

Dental Equipment Market
https://www.polarismarketresearch.com/industry-analysis/dental-equipment-market

Equine Healthcare Market
https://www.polarismarketresearch.com/industry-analysis/equine-healthcare-market

Immunoassay Market
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market

Heparin Calcium Market
https://www.polarismarketresearch.com/industry-analysis/heparin-calcium-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.